Augmentin and Co-codamol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Co-codamol (acetaminophen; codeine phosphate). Common drug interactions include aortic aneurysm among females and viral upper respiratory tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Co-codamol. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Co-codamol?

Co-codamol has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 2,364 Co-codamol users. Check the latest studies of Co-codamol.



On Jul, 09, 2026

20 people who take Augmentin and Co-codamol together, and have interactions are studied.

Augmentin and Co-codamol drug interactions.

What are the common drug interactions of Augmentin and Co-Codamol, by gender? *:

female:

  1. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Anaemia (lack of blood)
  4. Asthenia (weakness)
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Dyspnoea (difficult or laboured respiration)
  8. Faeces discoloured
  9. Haemorrhage (bleeding)
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Viral upper respiratory tract infection
  2. Injection site erythema (redness at injection site)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Depressed level of consciousness
  5. Epistaxis (bleed from the nose)
  6. Escherichia infection (bacterial infection by escherichia coli)
  7. Fall
  8. Frequent bowel movements
  9. Headache (pain in head)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the common drug interactions of Augmentin and Co-Codamol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Bladder spasm
  3. Epistaxis (bleed from the nose)
  4. Headache (pain in head)
  5. Influenza like illness
  6. Pneumonia

50-59:

  1. Viral upper respiratory tract infection
  2. Erythema infectiosum (infection that results in a mild rash on the face, trunk, and limbs)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Ankle fracture
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Depressed level of consciousness
  7. Escherichia infection (bacterial infection by escherichia coli)
  8. Fall
  9. Impaired healing
  10. Oxygen saturation decreased

60+:

  1. Injection site erythema (redness at injection site)
  2. Rash
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Hypophagia (reduced food intake)
  5. Hypotension (abnormally low blood pressure)
  6. Lethargy (tiredness)
  7. Pruritus (severe itching of the skin)
  8. Urine output decreased
  9. Haematemesis (vomiting of blood)
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Lower Respiratory Tract Infection: 8 people, 40.00%
  2. Abdominal Pain: 6 people, 30.00%
  3. Abdominal Pain Upper: 6 people, 30.00%
  4. Anaemia (lack of blood): 6 people, 30.00%
  5. Nausea (feeling of having an urge to vomit): 6 people, 30.00%
  6. Chest Pain: 6 people, 30.00%
  7. Multiple Myeloma (cancer of the plasma cells): 4 people, 20.00%
  8. Back Pain: 3 people, 15.00%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
  10. Gastric Ulcer (stomach ulcer): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Co-codamol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin and Co-codamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Co-codamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Co-codamol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and acetaminophen; codeine phosphate (the active ingredients of Augmentin and Co-codamol, respectively), and Augmentin and Co-codamol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: